Lifeward Appoints Almog Adar as CFO in Key Finance Leadership Move
PorAinvest
miércoles, 13 de agosto de 2025, 8:42 am ET2 min de lectura
LFWD--
Adar’s appointment comes as Lifeward’s stock price rises 4.12% premarket to $0.735, indicating investor confidence in the company's strategic direction and financial performance. Adar holds a Bachelor of Arts degree in Accounting and Economics from the Open University of Israel and is a Certified Public Accountant licensed by the Israeli Ministry of Justice. His expertise in auditing, financial reporting, and global business operations will be instrumental in driving Lifeward’s growth and strengthening its financial foundation.
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery. The company’s mission is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit. Founded in 2001, Lifeward has operations in the United States, Israel, and Germany.
Adar’s appointment follows the recent announcement of Mark Grant as the company’s President and Chief Executive Officer. Grant stated, "I am thrilled to welcome Almog to the executive leadership team. He has been an invaluable leader within our finance team and brings thoughtful leadership and a strong commitment to supporting Lifeward’s growth.”
Adar expressed his excitement about the new role, stating, "I am honored to step into the role of Chief Financial Officer at this pivotal moment for Lifeward. We have a tremendous opportunity ahead to build on our strengths, sharpen our execution, and accelerate growth. I am committed to working closely with our leadership team to deliver a clear, disciplined strategy, strengthen our financial foundation, and create lasting value for our patients, customers, and shareholders.”
The appointment of Adar as CFO underscores Lifeward’s commitment to financial stability and growth, positioning the company to continue its innovative work in medical technology. Investors can expect Adar to bring his extensive financial expertise to Lifeward, contributing to the company’s long-term success.
References
[1] https://finance.yahoo.com/news/lifeward-names-almog-adar-cfo-120000943.html
[2] https://seekingalpha.com/news/4484592-lifeward-appoints-almog-adar-as-cfo
Lifeward has appointed Almog Adar as its new CFO, effective immediately. Adar previously served as the company's vice president of finance and chief accounting officer, joining Lifeward in 2020 as director of finance and corporate financial controller. Prior to Lifeward, Adar worked as Controller of Infinya Recycling. The appointment comes as Lifeward's stock price rises 4.12% premarket to $0.735.
Lifeward Ltd. (Nasdaq: LFWD), a global leader in innovative medical technology, has appointed Almog Adar as its new Chief Financial Officer (CFO), effective immediately. Adar joins the executive leadership team from his previous role as Vice President of Finance and Chief Accounting Officer at Lifeward, where he played a key role in shaping the company’s financial strategy and supporting its growth. Prior to Lifeward, Adar served as Controller of Infinya Recycling Ltd. and as Assistant Controller at Delta Galil Industries, gaining extensive experience in complex financial management and global business operations.Adar’s appointment comes as Lifeward’s stock price rises 4.12% premarket to $0.735, indicating investor confidence in the company's strategic direction and financial performance. Adar holds a Bachelor of Arts degree in Accounting and Economics from the Open University of Israel and is a Certified Public Accountant licensed by the Israeli Ministry of Justice. His expertise in auditing, financial reporting, and global business operations will be instrumental in driving Lifeward’s growth and strengthening its financial foundation.
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery. The company’s mission is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit. Founded in 2001, Lifeward has operations in the United States, Israel, and Germany.
Adar’s appointment follows the recent announcement of Mark Grant as the company’s President and Chief Executive Officer. Grant stated, "I am thrilled to welcome Almog to the executive leadership team. He has been an invaluable leader within our finance team and brings thoughtful leadership and a strong commitment to supporting Lifeward’s growth.”
Adar expressed his excitement about the new role, stating, "I am honored to step into the role of Chief Financial Officer at this pivotal moment for Lifeward. We have a tremendous opportunity ahead to build on our strengths, sharpen our execution, and accelerate growth. I am committed to working closely with our leadership team to deliver a clear, disciplined strategy, strengthen our financial foundation, and create lasting value for our patients, customers, and shareholders.”
The appointment of Adar as CFO underscores Lifeward’s commitment to financial stability and growth, positioning the company to continue its innovative work in medical technology. Investors can expect Adar to bring his extensive financial expertise to Lifeward, contributing to the company’s long-term success.
References
[1] https://finance.yahoo.com/news/lifeward-names-almog-adar-cfo-120000943.html
[2] https://seekingalpha.com/news/4484592-lifeward-appoints-almog-adar-as-cfo

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios